- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01642953
Early Recovery After Gastric Cancer Surgery
Prospective Clinical Study for Early Recovery After Gastric Cancer Surgery
Study preparation
- To progress this prospective study, the investigators analyzed the retrospective data of 426 patients who had been managed with conventional critical pathway after gastric cancer surgery during last 1 year.
- Through this retrospective analysis, we decided the inclusion criteria which showed significantly the lower complication rate and shorter hospital stay.
Method for Prospective study
- Patients who enroll in this prospective study are administered and are supplied a liquid diet one day before surgery without bowel preparation.
- After gastric cancer surgery, they start sips of water on postoperative first day, and they are discharged once they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Enrollment of patients
- Before the patients are enrolled in this study, they give us informed consents.
- A liquid diet is supplied beginning from the morning of the day prior to operation to the midnight.
Operation and postoperative management
- All procedures are approached by laparoscopic surgery, and partial gastrectomy with lymph node dissection are performed.
- The patients who are considered to be difficult to progress early oral feeding in surgical field are excluded from the study.
- Nasogastric tube is not applied to patients.
- Postoperative pain is managed by non-opioid pain killer.
- The patients are started on sips of water on the first postoperative day.
- If they are tolerable, a liquid diet is started on the second postoperative day, and a soft diet on a third postoperative day for them.
- We have a plan to discharge the patients on the fourth postoperative day if they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination.
Evaluation of patients
- The patients are followed up to 30 days after discharge from hospital, and we check whether they are tolerable without any compliant and are readmitted.
Type d'étude
Inscription (Anticipé)
Phase
- Phase 2
Contacts et emplacements
Lieux d'étude
-
-
-
Suwon, Corée, République de, 443-721
- Recrutement
- Ajou University Hospital
-
Contact:
- Hoon Hur, prof.
- Numéro de téléphone: +82-31-219-5200
- E-mail: hhcmc75@naver.com
-
Contact:
- Sang-Uk Han, prof.
- Numéro de téléphone: +82-31-219-5200
- E-mail: hansu@ajou.ac.kr
-
Sous-enquêteur:
- Sang-Uk Han, Professor
-
Sous-enquêteur:
- Cheul Soo Byun, Instructor
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients who are diagnosed with gastric adenocarcinoma
- 65 years old and blew
- Patients are expected to be undergone distal subtotal gastrectomy
- No complication by gastric cancer
- No synchronous metastatic lesions
- Laparoscopic or robotic surgery
- Informed consent
Exclusion Criteria:
- Previous gastrectomy history
- Combined surgery due to synchronous malignancy
- Patients with major organ dysfunction
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Early recovery
Patients who enroll in this arm are supplied a liquid diet one day before surgery without bowel preparation. After gastric cancer surgery, they start sips of water on postoperative first day, and they are discharged once they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination. |
The patients are started on sips of water on the first postoperative day.
If they are tolerable, a liquid diet is started on the second postoperative day, and a soft diet on a third postoperative day for them.
We have a plan to discharge the patients on the fourth postoperative day if they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Drop rate from critical pathway
Délai: 4 days
|
It is defined as the proportion of dropped patients from 4 days critical pathway
|
4 days
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postoperative pain
Délai: 7 days
|
It is defined as the change of pain scale after surgery
|
7 days
|
|
Postoperative complication
Délai: 30 days
|
It is defined the complications after surgery
|
30 days
|
|
Postoperative mortality
Délai: 30 days
|
It will defined as the death case during 30 days after surgery
|
30 days
|
|
Recovery after surgery
Délai: 7 days
|
It is defined as the time to first flatus and recovery of bowel activity after surgery
|
7 days
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Hoon Hur, Prof., Ajou University School of Medicine
Publications et liens utiles
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AJIRB-MED-MDB-12-002
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .